by TractManager | Dec 29, 2016 | Health Technology Assessment
Purpose of Technology: Sugammadex (SUG) is indicated for the reversal of neuromuscular blockade (NMB) induced by rocuronium bromide and vecuronium bromide during surgery. SUG selectively binds to neuromuscular blocking agents, thereby preventing further...
by TractManager | Dec 29, 2016 | Health Technology Assessment
Purpose of Technology: Intravenous immunoglobulin (IVIG) has been investigated as a treatment for a variety of neurological disorders, including myasthenia gravis (MG), an autoimmune disease. The goal of IVIG for neurological disorders is to eliminate or reduce...
by TractManager | Dec 22, 2016 | Clinical Utility Evaluation
This report examines the clinical utility of genetic testing for germline variants in patients with a personal history of breast and/or ovarian cancer and a family history suggestive of hereditary breast and ovarian cancer (HBOC). This report provides an assessment of...
by TractManager | Dec 22, 2016 | Clinical Utility Evaluation
This report examines the clinical utility of genetic testing for hereditary hemorrhagic telangiectasia (HHT) in pediatric and adult patients who are symptomatic for HHT and/or have a family history of HHT. The evidence for the use of genetic testing is evaluated...
by TractManager | Dec 22, 2016 | Health Technology Assessment
Purpose of Technology: High-frequency chest wall compression (HFCWC) is a mechanical, external thoracic oscillatory therapy for cystic fibrosis (CF) patients whose ability to clear pulmonary secretions is impaired. The purpose of HFCWC is to promote effective...
Recent Comments